PCSK9 inhibitors

AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics
AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics
Pharmaforum
AstraZeneca
Dogma Therapeutics
cholesterol
PCSK9 inhibitors
Flag link:
ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half
ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half
Fierce Biotech
Novartis
ACC
PCSK9 inhibitors
inclisiran
Flag link:
MedCo's PCSK9 challenger steals the show at ESC with winning data
MedCo's PCSK9 challenger steals the show at ESC with winning data
Fierce Pharma
Medicines Company
ESC
PCSK9 inhibitors
inclisiran
Repatha
Praluent
European Society of Cardiology
Flag link:
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Flag link:
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Amgen
Regeneron
Sanofi
Praluent
Repatha
Medicines Company
PCSK9 inhibitors
inclisiran
Flag link:
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
Xconomy
PCSK9 inhibitors
Medicines Company
inclisiran
insurers
Flag link:
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
The Medicines Company
Amgen
Sanofi
Regeneron
inclisiran
PCSK9 inhibitors
Flag link:
Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen
Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen
Biopharma Dive
Regeneron
Sanofi
Amgen
Praluent
Repatha
drug pricing
PCSK9 inhibitors
Flag link:
New drug options, risk factors added to US heart guidelines
New drug options, risk factors added to US heart guidelines
Reuters
statins
PCSK9 inhibitors
Flag link:
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Fierce Pharma
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Supreme Court
Praluent
Repatha
Flag link:
Are These Disappointing Drugs Back on Track to Billions?
Are These Disappointing Drugs Back on Track to Billions?
Motley Fool
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
Praluent
Repatha
Flag link:
PCSK9s appear to be meeting less payer resistance
PCSK9s appear to be meeting less payer resistance
Biopharma Dive
PCSK9 inhibitors
payers
Flag link:
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
Forbes
cholesterol
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
Flag link:
NovoNordisk’s CSO openly addresses state of pharma sector
NovoNordisk’s CSO openly addresses state of pharma sector
GoinPharma
Novo Nordisk
Victoza
NASH
PCSK9 inhibitors
Flag link:
The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
Fierce Pharma
The Medicines Company
PCSK9 inhibitors
inclisiran
Vabomere
Flag link:
The Medicines Company PCSK9 Inhibitor Strategy: More Heart Patients Via Lower Pricing
The Medicines Company PCSK9 Inhibitor Strategy: More Heart Patients Via Lower Pricing
Forbes
The Medicines Company
PCSK9 inhibitors
drug pricing
inclisiran
Flag link:
The Medicine Company's Dangerous Bet On Its LDL Cholesterol Lowering Drug
The Medicine Company's Dangerous Bet On Its LDL Cholesterol Lowering Drug
Forbes
The Medicine Company
LDL cholesterol
inclisiran
Alnylam
PCSK9 inhibitors
Flag link:
PCSK9 court saga drags on for Sanofi, Regeneron and Amgen
PCSK9 court saga drags on for Sanofi, Regeneron and Amgen
Biopharma Dive
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
Praluent
Repatha
Flag link:
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Sanofi
Amgen
PCSK9 inhibitors
diabetes
Regeneron
Praluent
Repatha
Flag link:
Insurers, doctors battle over new heart disease drugs
Insurers, doctors battle over new heart disease drugs
CNBC
insurers
cardiovascular disease
statins
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
Flag link:

Pages